The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 16 Dec 2003
doi: 10.1242/jcs.00909
Research Article
The role of annexin 2 in osteoblastic mineralization
Jennifer M. Gillette
and
Sheila M. Nielsen-Preiss*
* Author for correspondence (e-mail: sheila.preiss{at}uchsc.edu)
While the basic cellular contributions to bone differentiation and mineralization are widely accepted, the regulation of these processes at the intracellular level remains inadequately understood. Our laboratory recently identified annexin 2 as a protein involved in osteoblastic mineralization. Annexin 2 was overexpressed twofold in SaOSLM2 osteoblastic cells as a fusion protein with green fluorescent protein. The overexpression of annexin 2 led to an increase in alkaline phosphatase activity as well as an increase in mineralization. Our data suggest that the increase in alkaline phosphatase activity does not result from increased alkaline phosphatase transcript or protein levels; therefore we evaluated mechanism of action. We determined that both annexin 2 and alkaline phosphatase activity were localized to membrane microdomains called lipid rafts in osteoblastic cells. Annexin 2 overexpression resulted in an increase in alkaline phosphatase activity that was associated with lipid microdomains in a cholesterol-dependent manner. Furthermore, disruption of lipid rafts with a cholesterol sequestering agent or reduction of annexin 2 expression by specific antisense oligonucleotides each resulted in diminished mineralization. Therefore, intact lipid rafts containing annexin 2 appear to be important for alkaline phosphatase activity and may facilitate the osteoblastic mineralization process.
This article has been cited by other articles:

|
 |

|
 |
 
N. X. Chen, K. D. O'Neill, X. Chen, D. Duan, E. Wang, M. S. Sturek, J. M. Edwards, and S. M. Moe
Fetuin-A uptake in bovine vascular smooth muscle cells is calcium dependent and mediated by annexins
Am J Physiol Renal Physiol,
February 1, 2007;
292(2):
F599 - F606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-L. Tso, P. Shintaku, J. Chen, Q. Liu, J. Liu, Z. Chen, K. Yoshimoto, P. S. Mischel, T. F. Cloughesy, L. M. Liau, et al.
Primary Glioblastomas Express Mesenchymal Stem-Like Properties
Mol. Cancer Res.,
September 1, 2006;
4(9):
607 - 619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. McCormick, F. Rahimi, Y. V. Bobryshev, K. Gaus, H. Zreiqat, H. Cai, R. S. A. Lord, and C. L. Geczy
S100A8 and S100A9 in Human Arterial Wall: IMPLICATIONS FOR ATHEROGENESIS
J. Biol. Chem.,
December 16, 2005;
280(50):
41521 - 41529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Baldwin, V. G. Nolan, D. F. Wyszynski, Q.-L. Ma, P. Sebastiani, S. H. Embury, A. Bisbee, J. Farrell, L. Farrer, and M. H. Steinberg
Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis
Blood,
July 1, 2005;
106(1):
372 - 375.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2003